Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 1,908,697 | 1,760,817 | 1,906,405 | 1,903,201 | 1,821,577 |
| Cost of Goods | 1,109,164 | 1,045,034 | 1,116,574 | 1,104,394 | 1,096,998 |
| Gross Profit | 799,533 | 715,783 | 789,831 | 798,807 | 724,579 |
| Operating Expenses | 501,878 | 398,684 | 468,352 | 482,347 | 694,617 |
| Operating Income | 297,819 | 317,133 | 322,053 | 316,854 | 30,960 |
| Interest Expense | 42,102 | 42,082 | 43,408 | 46,581 | 37,929 |
| Other Income | 12,365 | 9,946 | 4,624 | 7,523 | 9,907 |
| Pre-tax Income | 268,082 | 284,997 | 283,269 | 277,796 | 2,938 |
| Income Tax | 102,562 | 98,886 | 101,126 | 105,762 | 49,226 |
| Net Income Continuous | 165,520 | 186,111 | 182,143 | 172,034 | -46,288 |
| Net Income Discontinuous | 2,995 | 13,131 | -250 | -507 | -374 |
| Minority Interests | 9,397 | 9,372 | 10,045 | 8,384 | 7,199 |
| Net Income | $159,118 | $189,870 | $171,848 | $163,143 | $-53,861 |
| EPS Basic Total Ops | 1.00 | 1.17 | 1.08 | 1.03 | -0.33 |
| EPS Basic Continuous Ops | 0.98 | 1.10 | 1.08 | 1.03 | -0.33 |
| EPS Basic Discontinuous Ops | 0.02 | 0.08 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.99 | 1.16 | 1.07 | 1.02 | -0.33 |
| EPS Diluted Continuous Ops | 0.97 | 1.08 | 1.08 | 1.02 | -0.33 |
| EPS Diluted Discontinuous Ops | 0.02 | 0.09 | -0.01 | 0.00 | 0.00 |
| EBITDA(a) | $369,993 | $388,702 | $395,400 | $389,573 | $94,325 |